C07D 207/456
With hetero atoms or with carbon atoms having three bonds to hetero
Official title: with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
C07D207/456 (With hetero atoms or with carbon atoms having three bonds to hetero) appears on 125 US grants and 80 published applications in this corpus.
Search patents in C07D- Granted patents
- 125
- Published applications
- 80
- Assignees
- 82
- Inventors
- 348
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 4 | 0 |
| 1983 | 1 | 0 |
| 1984 | 14 | 0 |
| 1985 | 4 | 0 |
| 1986 | 5 | 0 |
| 1987 | 5 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 6 | 0 |
| 1991 | 5 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 1 | 4 |
| 2005 | 3 | 3 |
| 2006 | 1 | 3 |
| 2007 | 1 | 0 |
| 2008 | 1 | 5 |
| 2009 | 3 | 2 |
| 2010 | 4 | 1 |
| 2011 | 1 | 3 |
| 2012 | 0 | 5 |
| 2013 | 3 | 1 |
| 2014 | 2 | 4 |
| 2015 | 0 | 1 |
| 2016 | 2 | 3 |
| 2017 | 1 | 2 |
| 2018 | 1 | 6 |
| 2019 | 5 | 8 |
| 2020 | 3 | 5 |
| 2021 | 8 | 4 |
| 2022 | 4 | 3 |
| 2023 | 1 | 5 |
| 2024 | 2 | 1 |
| 2025 | 3 | 6 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- N/O-linked degrons and degronimers for protein degradation14 Oct 2025US 12,441,740 B2C4 Therapeutics, Inc.
- Compositions and methods for viral sensitization14 Jan 2025US 12,195,451 B2Ottawa Hospital Research Institute and University of Ottawa
- Linker for antibody-drug conjugates and its use14 Jan 2025US 12,195,552 B2Remegen Co., Ltd.
- N/O-linked degrons and degronimers for protein degradation31 Dec 2024US 12,180,225 B2C4 Therapeutics, Inc.
- Covalent, chemogenetic activators for k2p potassium channels and uses thereof9 Apr 2026US 2026/0098008 A1The Regents of the University of California
- Organic compound, light-emitting device including the organic compound, electronic apparatus including the light-emitting device, and electronic equipment including the electronic apparatus26 Mar 2026US 2026/0090268 A1Samsung Display Co., Ltd.
- N/o-linked degrons and degronimers for protein degradation15 Jan 2026US 2026/0015362 A1C4 Therapeutics, Inc.
- System and method of wagering on a plurality of events5 Jun 2025US 2025/0182584 A1Exacta Systems, LLC
- Linker for antibody-drug conjugates and its use8 May 2025US 2025/0145731 A1Remegen Co., Ltd.
Most cited
By later US patents
- 2-(2-imidazolin-2-yl)-pyridines and quinolines and use of said compounds as herbicidal agents49US 4,798,619 AAmerican Cyanamid Company · 1989
- 2-(2-imidazolin-2-yl)-pyridines and quinolines, process and intermediates for the preparation thereof, and use of said compounds as herbicidal agents48US 4,638,068 AAmerican Cyanamid Company · 1987
- 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase42US 4,342,776 AMerck & Co., Inc. · 1982
- Ether imides and process for producing the same33US 4,460,783 AHitachi, Ltd. · 1984
- Preparation of N-substituted oligo-imides29US 4,225,497 ARhone-Poulenc Industries · 1980